What topics does this cannabis study cover?

This study covers research on: Endocannabinoid, THC, Neuroprotection, Mental Health.

Where was this research published?

Published in bioRxiv : the preprint server for biology on September 15, 2026.

Endocannabinoid THC Neuroprotection Mental Health

Prenatal cannabinoid exposure shifts dopamine-cell plasticity in male rats

Q: What did this research study find?

In male rat offspring exposed to cannabinoids prenatally, *endocannabinoid*-mediated plasticity at excitatory inputs to VTA dopamine neurons was absent.

An endocannabinoid-nitric oxide signaling switch triggers reciprocal inhibitory-excitatory plasticity at dopamine neuron inputs following prenatal cannabinoid exposure.

bioRxiv : the preprint server for biology • September 15, 2026 • Highly Relevant

🤖

AI Summary

This rat study asked how prenatal cannabinoid exposure (PCE) affects endocannabinoid-mediated synaptic plasticity in dopamine neurons. In male offspring, endocannabinoid-mediated plasticity at excitatory inputs to dopamine neurons in the ventral tegmental area was absent. The researchers report that the organization of excitatory inputs was altered, impairing CB1 receptor control of glutamate release.

The abstract reports a shift toward nitric oxide signaling: after dopamine cells were depolarized, this signaling produced increased strength at inhibitory inputs and decreased strength at excitatory inputs. Together, these changes reshaped the balance of inputs to dopamine neurons and may contribute to abnormal dopamine activity and vulnerability to psychiatric disorders. This is an abstract-based summary of findings in a rat model; it cannot establish effects of prenatal cannabis exposure in humans or show that these circuit changes cause psychiatric disorders.

💡 Key Findings

In male rat offspring exposed to cannabinoids prenatally, endocannabinoid-mediated plasticity at excitatory inputs to VTA dopamine neurons was absent.

High

90%

After postsynaptic depolarization, the exposed animals’ dopamine cells used nitric oxide signaling to produce opposing plasticity: stronger inhibitory and weaker excitatory synaptic transmission.

High

90%

The reported synaptic changes reshape excitatory and inhibitory control of dopamine neurons and may contribute to abnormal dopamine activity; the abstract does not establish that they cause psychiatric disorders.

High

85%

📄 Original Abstract

UNLABELLED: Dynamic regulation of midbrain dopamine neuron activity is necessary for diverse processes including motivation, novelty detection, reinforcement learning, and cognitive flexibility. By setting the strength of synaptic inputs to dopaminergic neurons, endocannabinoid signaling is essential for regulating dopaminergic activity. Prenatal exposure to Δ9-tetrahydrocannabinol (THC), the main psychoactive substance in cannabis, is known to induce abnormal dopaminergic activity and increased susceptibility to psychopathology. However, how prenatal cannabinoid exposure (PCE) affects endocannabinoid-mediated synaptic plasticity of dopamine neurons remains largely unknown. Here, we use a rat model of PCE to directly determine this. We found that endocannabinoid-mediated synaptic plasticity at excitatory synapses on dopamine neurons of the ventral tegmental area (VTA) was absent in PCE male rat offspring, where the presynaptic nanoscale architecture of excitatory afferents onto VTA dopamine neurons was reorganized to impair the control of type-1 cannabinoid receptors on glutamate release. We demonstrate that, in response to postsynaptic depolarization, PCE dopamine cells switch to nitric oxide (NO) rather than endocannabinoid signaling to induce opposing forms of synaptic plasticity at inhibitory and excitatory inputs. We disclosed a NO-dependent long-term potentiation of GABA A -receptor-mediated synaptic transmission, and a long-term depression of glutamatergic synapses requiring presynaptic activation of GABA B -receptors. These PCE-induced reciprocal forms of synaptic plasticity reshape the balance of excitatory and inhibitory control over dopamine neurons, potentially contributing to increased vulnerability to psychiatric disorders. SIGNIFICANCE STATEMENT: Endocannabinoids (eCBs) in the midbrain regulate dopamine cell activity and plasticity to guide behavior. eCBs retrogradely activate presynaptic type-1 cannabinoid receptors to depress synaptic transmission. Here, we identify metaplastic changes driven by prenatal cannabinoid exposure (PCE) on eCB signaling at excitatory afferents on dopamine neurons. These include a switch in retrograde signaling favoring de novo synthesis of nitric oxide (NO) to replace the actions of eCBs, which are compromised at excitatory inputs. NO induces novel forms of long-term plasticity at excitatory and inhibitory inputs on male dopamine neurons. These forms of metaplasticity may be recruited in the VTA in response to PCE-induced circuit remodeling, and the resulting synaptic adaptations contribute to abnormal dopamine cell activity.